1. Home
  2. MBIO vs CREV Comparison

MBIO vs CREV Comparison

Compare MBIO & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • CREV
  • Stock Information
  • Founded
  • MBIO 2015
  • CREV 2007
  • Country
  • MBIO United States
  • CREV Ireland
  • Employees
  • MBIO N/A
  • CREV N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • CREV
  • Sector
  • MBIO Health Care
  • CREV
  • Exchange
  • MBIO Nasdaq
  • CREV Nasdaq
  • Market Cap
  • MBIO 7.3M
  • CREV 7.2M
  • IPO Year
  • MBIO N/A
  • CREV N/A
  • Fundamental
  • Price
  • MBIO $2.93
  • CREV $3.95
  • Analyst Decision
  • MBIO Strong Buy
  • CREV Strong Buy
  • Analyst Count
  • MBIO 1
  • CREV 1
  • Target Price
  • MBIO $100.00
  • CREV $39.00
  • AVG Volume (30 Days)
  • MBIO 411.9K
  • CREV 319.8K
  • Earning Date
  • MBIO 03-10-2025
  • CREV 01-01-0001
  • Dividend Yield
  • MBIO N/A
  • CREV N/A
  • EPS Growth
  • MBIO N/A
  • CREV N/A
  • EPS
  • MBIO N/A
  • CREV N/A
  • Revenue
  • MBIO N/A
  • CREV $39,261,077.00
  • Revenue This Year
  • MBIO N/A
  • CREV $40.76
  • Revenue Next Year
  • MBIO N/A
  • CREV $86.18
  • P/E Ratio
  • MBIO N/A
  • CREV N/A
  • Revenue Growth
  • MBIO N/A
  • CREV 41.52
  • 52 Week Low
  • MBIO $2.61
  • CREV $2.00
  • 52 Week High
  • MBIO $74.50
  • CREV $22.34
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 29.06
  • CREV 43.26
  • Support Level
  • MBIO $3.96
  • CREV $3.42
  • Resistance Level
  • MBIO $6.70
  • CREV $4.34
  • Average True Range (ATR)
  • MBIO 0.87
  • CREV 0.92
  • MACD
  • MBIO -0.07
  • CREV -0.08
  • Stochastic Oscillator
  • MBIO 7.94
  • CREV 11.87

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Share on Social Networks: